Page 845 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 845

INDEX                                                                                        INDEX                     801




                    diuretic effects on, 609  Vagal nuclei, 506         Vasculitides, 314–315     Ventricular fibrillation
                    leaks with urethral injury, 627  Vagina             Vasculitis                  ECG tracing, 295
                    osmolality in acute injury, 601  anatomy of, 626     focal necrotizing, 315     torsades de pointes, 294
                    pregnancy test, 633        drainage of, 624          immunoglobulin A, 315    Ventricular filling
                    renal tubular acidosis, 593  epithelial histology of, 626  intraparenchymal hemorrhage,    early diastole, 287
                  Urine acidification, 233     genital embryology, 622        513                   ECG and, 293
                  Urine alkalization, 233    Vaginal bleeding            large-vessel, 314        Ventricular free wall rupture, 307
                  Urine pH and drug elimination, 233  cervical cancer, 645  leukoclastic, 173     Ventricular myocytes, 296
                  Urobilinogen               Vaginal candidiasis         medium-vessel, 314       Ventricular noncompliance, 287
                    extravascular hemolysis, 421  nystatin, 199          methotrexate for, 440    Ventricular septal defect (VSD),
                    intravascular hemolysis, 421  Vaginal infections, 181  small-vessel, 314            299
                  Urogenital fold, 624       Vaginal tumors, 644        Vasculopathy                congenital rubella, 300
                  Urosepsis, 600             Vaginismus, 567             noninflammatory, 473       cri-du-chat syndrome, 64
                  Urothelial carcinoma (bladder), 606  Vaginitis        Vas deferens, 626           Down syndrome, 300
                  Urticaria, 475, 477          Trichomonas spp, 158, 181  Vasoactive intestinal polypeptide   fetal alcohol syndrome, 300
                    ethosuximide, 544          trichomoniasis, 184            (VIP), 371            heart murmurs, 291
                    scombroid poisoning, 247  Vagus nerve (CN X), 506   Vasoconstriction, 589       outflow tract formation, 281
                    serum sickness, 113        baroreceptors/chemoreceptors   Vasoconstrictors, 550  Ventricular system, 504
                    sulfa drug allergies, 252      and, 296             Vasodilation              Ventriculomegaly, 520, 522
                    as type I hypersensitivity, 112  cardiac glycoside effects, 321  sympathetic receptors, 238  Ventromedial nucleus
                  USMLE Step 1 exam            Curling ulcers and, 379  Vasodilators                    (hypothalamus), 498
                    check-in process, 7        diaphragm innervation, 663  afterload effects, 284  Verapamil, 308, 318, 319, 321, 518
                    clinical vignette strategies, 23  gastrointestinal regulation   aortic dissections, 303  Verrucae, 477
                    content areas covered in, 3    substances and, 371   atrial natriuretic peptide as, 296  Vertebral compression fractures,
                    goal-setting for, 12       lesions of, 532           coronary steal syndrome, 304   462
                    leaving exam early, 8      pharyngeal arch derivation,    nitrates as, 318    Vertebral landmarks
                    overview of, 2                 620                  Vasogenic edema, 496        diaphragm, 663
                    passing rates for, 10      structures innervated, 373  Vasopressin, 329       Vertigo, 534
                    practice exams for, 11, 21–22  tongue, 493           receptors, 238             posterior circulation stroke, 514
                    registering for, 5–6     Valacyclovir, 201          Vasopressors, 286           streptomycin, 197
                    rescheduling, 6          Validity, 259              V(D)J recombination, 99   Vesicles (skin), 475
                    score notifications for, 7  Valine                  VDRL false positives, 148   varicella zoster virus, 479
                    scoring of, 8–9            classification of, 81    Vector-borne illnesses, 150  Vesicourachal diverticulum, 618
                    testing agencies, 24       maple syrup urine disease, 84  Veganism and B  deficiency, 420  Vesicoureteral reflux, 579
                                                                                  12
                    testing locations, 6     Valproic acid             Vegetative state             hydronephrosis, 599
                    test-taking strategies, 22–23  cytochrome P-450, 252  axonal injury and, 515    pyelonephritis, 600
                    time budgeting during, 7–8  epilepsy, 544          VEGF (vascular endothelial growth   Vesicular monoamine transporter
                    types of questions on, 8   hepatic necrosis, 249          factor), 216              (VMAT), 549
                  Ustekinumab, 122             migraine headaches, 518  Velocardiofacial syndrome, 116  Vesicular tinea pedis, 152
                  Uterine conditions           pancreatitis, 249       Vemurafenib, 444, 484      Vesicular trafficking proteins, 47
                    non-neoplastic, 648      Valsartan, 610            Venlafaxine, 575           Vestibular schwannomas, 527
                  Uterine (Müllerian duct) anomalies,   Valvular disease  clinical use, 572       Vestibulocochlear nerve (CN VIII),
                         622–623               pressure-volume loops, 288  panic disorder, 563          506
                  Uterine neoplasms, 648     Valvular dysfunction, 310   phobias, 563             VHL gene, 224
                  Uterovaginal agenesis, 639  Vancomycin, 190            PTSD, 564                Vibrio cholerae, 146
                  Uterus                       Clostridium difficile, 138  Venodilators, 284        exotoxin production, 132
                    anomalies of, 623          cutaneous flushing, 248  Venous gonadal drainage, 624  watery diarrhea, 179
                    collagen in, 50            meningitis, 180         Venous return, 286         Vibrio parahaemolyticus, 178
                    epithelial histology, 626  MRSA, 198               Venous sinus thrombosis, 503  Vibrio vulnificus, 178
                    genital embryology, 622    toxicity of, 251        Venous thrombosis          Vigabatrin, 544
                    zygote implantation, 633  Vanillylmandelic acid (VMA)  heparin for, 436       Vilazodone, 576
                  Uveitis, 536                 in neuroblastomas, 350    paroxysmal nocturnal     Vimentin, 48, 227
                    inflammatory bowel disease, 382  Vanishing bile duct syndrome,    hemoglobinuria, 422  Vinblastine, 441
                    in sarcoidosis, 676            119                 Ventilation, 664             microtubules and, 48
                    seronegative spondyloarthritis, 469  Varenicline, 576  high altitude, 670     Vinca alkaloids, 438
                  U wave in ECG, 293         Variable expressivity, 56   perfusion and, 669       Vincristine, 441
                                             Variance, 262             Ventilation/perfusion (V/Q) defects,   microtubules and, 48
                  V                          Variant angina, 304              664                   toxicities of, 444
                  Vaccines                   Variceal bleeding, 245    Ventilation/perfusion (V/Q) ratio  Vinyl chloride
                    B-cell disorders, 116    Varicella zoster virus (VZV), 165,   exercise response, 670  angiosarcomas, 392, 478
                    Bordetella pertussis, 143      475, 479              mismatch, 669              as carcinogen, 225
                    capsular polysaccharide and   guanosine analogs, 201  Ventral lateral (VL) nucleus, 498  VIPomas
                         protein conjugates in, 127  immunodeficient patients, 118  Ventral pancreatic bud, 360  MEN 1 syndrome, 351
                    diphtheria, 139            meningitis, 180         Ventral posterolateral (VPL) nucleus,   octreotide for, 400
                    encapsulated bacteria, 127  rash, 183                     498                   regulatory substances, 371
                    Haemophilus influenzae, 142, 180  vaccine, 110     Ventral posteromedial (VPM)   Viral envelopes, 163
                    Poliovirus, 167          Varices                          nucleus, 498        Virchow nodes, 379
                    PPSV23, 105                Budd-Chiari syndrome, 392  Ventral tegmentum, 495  Viridans streptococci, 136
                    rabies, 171              Varicocelectomy, 651      Ventricles                   α-hemolysis, 135
                    rotavirus, 168           Varicocele (scrotal), 628, 651  contractility of, 285  bacterial endocarditis, 311
                    Salmonella typhi, 144    Vasa previa, 641            embryology, 281            biofilm production, 128
                    splenectomy and, 98      Vasa vasorum                morphogenesis of, 281      brain abscesses, 180
                    thymus-independent antigens,    syphilis, 147      Ventricular action potential, 292  gram-positive algorithm, 134
                         105                 Vascular dementia, 521    Ventricular aneurysm         normal flora, 178
                    toxoids as, 131          Vascular function curves, 286  pseudoaneurysm, 307   Virilization, 335
                    types of, 111            Vascular tumors of skin, 478  true, 305, 307         Virology, 162–177







          FAS1_2019_21_Index_749-806.indd   801                                                                        11/21/19   12:27 PM
   840   841   842   843   844   845   846   847   848   849   850